发明名称 CRYSTALLINE EFAVIRENZ
摘要 <p>The potent reverse transcriptase inhibitor Efavirenz is produced in crystalline form. Crystalline Efavirenz exists in several physical forms which are designated Forms 1, 2, 3, 4 and 5 and are characterized by x-ray powder diffraction and differential scanning calorimetry. Pharmaceutical compositions and methods are useful for the treatment of the human immunodeficiency virus (HIV).</p>
申请公布号 SK18182000(A3) 申请公布日期 2001.08.06
申请号 SK20000001818 申请日期 1999.06.10
申请人 DUPONT PHARMACEUTICALS COMPANY 发明人 RADESCA LILIAN A.;MAURIN MICHAEL B.;RABEL SHELLEY R.;MOORE JAMES R.
分类号 A61K31/536;A61P31/18;A61P37/04;C07D265/18;(IPC1-7):C07D265/18;A61K31/535 主分类号 A61K31/536
代理机构 代理人
主权项
地址